As of April 18, 2025, Nfl Biosciences SAS (ALNFL.PA) has a market cap of $15.460 million USD. According to our data, Nfl Biosciences SAS is ranked No.8653 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $15.46 M |
-28.37%
|
Dec 31, 2024 | $21.58 M |
36.81%
|
Dec 29, 2023 | $15.78 M |
-26.72%
|
Dec 30, 2022 | $21.53 M |
-18.13%
|
Dec 31, 2021 | $26.29 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.24 B |
0.000 M
|
![]() Ireland
|
![]() Corbus Pharmaceuticals
CRBP
|
$73.76 M |
0.000 M
|
![]() USA
|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Tilray
TLRY
|
$0.45 B |
0.000 M
|
![]() Canada
|
![]() Aurora Cannabis
ACB
|
$0.24 B |
0.000 M
|
![]() Canada
|
![]() Canopy Growth
CGC
|
$0.21 B |
28.681 M
|
![]() Canada
|
![]() Cronos Group
CRON
|
$0.68 B |
-0.000 M
|
![]() Canada
|
![]() OrganiGram Holdings
OGI
|
$0.14 B |
-0.000 M
|
![]() Canada
|
Market Cap | = | ALNFL.PA Stock Price | * | ALNFL.PA Shares Outstanding |
= | $1.57 | * | 9.83 M | |
= | $15.46 M |